BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26679375)

  • 1. Severe obesity prior to diagnosis limits survival in colorectal cancer patients evaluated at a large cancer centre.
    Daniel CR; Shu X; Ye Y; Gu J; Raju GS; Kopetz S; Wu X
    Br J Cancer; 2016 Jan; 114(1):103-9. PubMed ID: 26679375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Body Mass Index and Mortality in Patients With Colorectal Cancer Using Causal Diagrams.
    Kroenke CH; Neugebauer R; Meyerhardt J; Prado CM; Weltzien E; Kwan ML; Xiao J; Caan BJ
    JAMA Oncol; 2016 Sep; 2(9):1137-45. PubMed ID: 27196302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-diagnostic body mass index and weight change in relation to colorectal cancer survival among incident cases from a population-based cohort study.
    Laake I; Larsen IK; Selmer R; Thune I; Veierød MB
    BMC Cancer; 2016 Jul; 16():402. PubMed ID: 27387027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of alcohol intake, smoking, physical activity and obesity with survival following colorectal cancer diagnosis by stage, anatomic site and tumor molecular subtype.
    Jayasekara H; English DR; Haydon A; Hodge AM; Lynch BM; Rosty C; Williamson EJ; Clendenning M; Southey MC; Jenkins MA; Room R; Hopper JL; Milne RL; Buchanan DD; Giles GG; MacInnis RJ
    Int J Cancer; 2018 Jan; 142(2):238-250. PubMed ID: 28921583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic relevance of prediagnostic weight loss and overweight at diagnosis in patients with colorectal cancer.
    Walter V; Jansen L; Hoffmeister M; Ulrich A; Roth W; Bläker H; Chang-Claude J; Brenner H
    Am J Clin Nutr; 2016 Oct; 104(4):1110-1120. PubMed ID: 27581471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of prediagnostic body mass index with survival after colorectal cancer: Stage-specific associations.
    Kocarnik JM; Chan AT; Slattery ML; Potter JD; Meyerhardt J; Phipps A; Nan H; Harrison T; Rohan TE; Qi L; Hou L; Caan B; Kroenke CH; Strickler H; Hayes RB; Schoen RE; Chong DQ; White E; Berndt SI; Peters U; Newcomb PA
    Int J Cancer; 2016 Sep; 139(5):1065-72. PubMed ID: 27121247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excess body weight and colorectal cancer survival: the multiethnic cohort.
    Maskarinec G; Harmon BE; Little MA; Ollberding NJ; Kolonel LN; Henderson BE; Le Marchand L; Wilkens LR
    Cancer Causes Control; 2015 Dec; 26(12):1709-18. PubMed ID: 26358830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of body mass index on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort.
    Campbell PT; Newton CC; Dehal AN; Jacobs EJ; Patel AV; Gapstur SM
    J Clin Oncol; 2012 Jan; 30(1):42-52. PubMed ID: 22124093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline serum C-reactive protein and death from colorectal cancer in the NHANES III cohort.
    Swede H; Hajduk AM; Sharma J; Rawal S; Rasool H; Vella AT; Tobet RE; Stevens RG
    Int J Cancer; 2014 Apr; 134(8):1862-70. PubMed ID: 24122448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin use and survival after colorectal cancer: the importance of comprehensive confounder adjustment.
    Hoffmeister M; Jansen L; Rudolph A; Toth C; Kloor M; Roth W; Bläker H; Chang-Claude J; Brenner H
    J Natl Cancer Inst; 2015 Jun; 107(6):djv045. PubMed ID: 25770147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral Adiposity is a Risk Factor for Poor Prognosis in Colorectal Cancer Patients Receiving Adjuvant Chemotherapy.
    Lee CS; Murphy DJ; McMahon C; Nolan B; Cullen G; Mulcahy H; Sheahan K; Barnes E; Fennelly D; Ryan EJ; Doherty GA
    J Gastrointest Cancer; 2015 Sep; 46(3):243-50. PubMed ID: 25832480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Body mass index and cancer incidence:a prospective cohort study in northern China].
    Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint prognostic effect of obesity and chronic systemic inflammation in patients with metastatic colorectal cancer.
    Shah MS; Fogelman DR; Raghav KP; Heymach JV; Tran HT; Jiang ZQ; Kopetz S; Daniel CR
    Cancer; 2015 Sep; 121(17):2968-75. PubMed ID: 25975416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity is a risk factor for multifocal disease and recurrence after colorectal cancer surgery: a case-control study.
    Scarpa M; Ruffolo C; Erroi F; Fiorot A; Basato S; Pozza A; Canal F; Massani M; Cavallin F; Antoniutti M; Bassi N; Castoro C
    Anticancer Res; 2014 Oct; 34(10):5735-41. PubMed ID: 25275082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking and survival of colorectal cancer patients: population-based study from Germany.
    Walter V; Jansen L; Hoffmeister M; Ulrich A; Chang-Claude J; Brenner H
    Int J Cancer; 2015 Sep; 137(6):1433-45. PubMed ID: 25758762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival outcomes of obese patients in type II endometrial cancer: Defining the prognostic impact of increasing BMI.
    Billingsley CC; Cansino C; O'Malley DM; Cohn DE; Fowler JM; Copeland LJ; Backes FJ; Salani R
    Gynecol Oncol; 2016 Mar; 140(3):405-8. PubMed ID: 26801939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of body mass index and physical activity on mortality among patients with colorectal cancer in Queensland, Australia.
    Baade PD; Meng X; Youl PH; Aitken JF; Dunn J; Chambers SK
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1410-20. PubMed ID: 21558496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer.
    Dignam JJ; Polite BN; Yothers G; Raich P; Colangelo L; O'Connell MJ; Wolmark N
    J Natl Cancer Inst; 2006 Nov; 98(22):1647-54. PubMed ID: 17105987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of BMI with overall survival in patients with mCRC who received chemotherapy versus EGFR and VEGF-targeted therapies.
    Patel GS; Ullah S; Beeke C; Hakendorf P; Padbury R; Price TJ; Karapetis CS
    Cancer Med; 2015 Oct; 4(10):1461-71. PubMed ID: 26211512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of obesity and overweight with overall survival in colorectal cancer patients: a meta-analysis of 29 studies.
    Wu S; Liu J; Wang X; Li M; Gan Y; Tang Y
    Cancer Causes Control; 2014 Nov; 25(11):1489-502. PubMed ID: 25070668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.